Medical/Pharmaceuticals

As COVID-19 Recovery Numbers Increase, Government Emphasise the Importance of Maintaining the Body's Immunity

* Decrease the risk of infection with 3 effective acts to increase the body's immunity ahead of the COVID-19 vaccine. * Early detection of symptoms is key to overcoming a COVID-19 case. * With a disciplined approach, Indonesia can overcome the pandemic. JAKARTA, Indonesia, Nov. 18, 2020 /PRN...

2020-11-18 16:47 1544

Chinese biotech company releases rapid COVID-19 antigen test with easy-to-use nasal swab

BINHAI, China, Nov. 18, 2020 /PRNewswire/ -- JOYSBIO Biotechnology Co., Ltd. announced today that they have introduced a new rapid COVID-19 antigen test kit available to medical facilities around the world as well as direct-to-consumer for at-home testing depending on local legislation. The kit ...

2020-11-18 16:38 2324

Cipla launches 'Covi-G' for COVID-19 rapid antibody detection

MUMBAI, India, Nov. 18, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as "Cipla") today announced that it signed a licensing agreement with aBelgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across most Emergin...

2020-11-18 16:36 3896

Kazia Presents Further Paxalisib Data At Sno, Confirming Earlier Positive Safety And Efficacy Signals In Glioblastoma

SYDNEY, Nov. 18, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a summary of new paxalisib data presented at the Society for Neuro-Oncology (SNO) Annual Meeting, which is being held virtually from...

2020-11-18 07:39 3146

Alzheimer's Disease Data Initiative launches new AD Workbench to foster greater global research innovation and accelerate breakthroughs in Alzheimer's disease and related dementias

Platform gives scientists open access to more data and new tools SEATTLE, Nov. 18, 2020 /PRNewswire/ -- Launching today is the Alzheimer's Disease Data Initiative (ADDI) and its Alzheimer's disease (AD)Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations fo...

2020-11-18 03:20 2284

Sensium Lauded by Frost & Sullivan for Enhancing Patient Outcomes with its Wireless Patient Monitoring Tool

The Sensium System provides accurate and continuous monitoring for early detection of patient deterioration in hospital wards LONDON, Nov. 18, 2020 /PRNewswire/ -- Based on its recent analysis of the European wearable remote patient monitoring market, Frost & Sullivan recognizes TSC Connected Car...

2020-11-18 00:51 1571

Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM)

MAINLAND CHINA * Regent Pacific to receive a total payment of US$4 million upon the receipt of approval from the National Medical Products Administration (NMPA) for conducting human trial * China is expected to be the single largest market for Sendstend™ UNITED STATES * The Phase II valid...

2020-11-17 22:09 3545

Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform for generative chemistry

HONG KONG, Nov. 17, 2020 /PRNewswire/ -- Following the release of Chemistry42 to a select group of key experts in the pharmaceutical industry in Q3 2020, Insilico Medicine is proud to announce that Merck KGaA, Darmstadt, Germany will be the first launch partner for its flagship generative chemistr...

2020-11-17 22:00 2085

Hack Your Brain To A Better Sleep: Muse S Introduces Lab-Grade Sleep Tracking and Brain-Powered Sleep Insights

TORONTO, Nov. 17, 2020 /CNW/ - Muse®by Interaxon Inc., a leading consumer neurotechnology and meditation company, today announced the launch of its newest feature, overnight sleep tracking for their latest device model,Muse® S. This new feature release will be available at no additional cost thro...

2020-11-17 22:00 1345

Russia is considered a highly trusted vaccine manufacturer and almost half of respondents in 11 countries are aware of Sputnik V, a YouGov poll shows

MOSCOW, Nov. 17, 2020 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), announces the results of a survey of more than 12,000 respondents in 11 countries on their attitude towards vaccination against coronavirus and their vaccine preferences. According to ...

2020-11-17 21:38 1203

Foxx Life Sciences Announces Opening of New Asia Headquarters in India

SALEM, New Hampshire, Nov. 17, 2020 /PRNewswire/ -- Foxx Life Sciences announced on Tuesday that it will open the new internationalAsia headquarters in Medchal,Hyderabad, India. The latest expansion comes with strong growth and performance inAsia and the continued expansion of Biopharmaceutical ...

2020-11-17 21:00 1177

Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety

TIANJIN, China, Nov. 17, 2020 /PRNewswire/ -- SINOMED® today announced that Prof.Alexandra Lansky from the Yale School of Medicine, USA, presented data from its first inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (Healing-Targeted) Drug-Eluting Stent, t...

2020-11-17 18:49 2077

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect

2020-11-17 16:29 1593

Visiopharm's AI-Powered Image Analysis Software Selected to Analyze the Largest Collection of Human Pathology Specimens in the World

DENVER and HOERSHOLM, Denmark, Nov. 17, 2020 /PRNewswire/ -- Visiopharm, the leader in artificial intelligence-driven image analysis, tissue mining, and precision pathology, has been selected by the Joint Pathology Center (JPC), the premier pathology reference center forthe United States federal ...

2020-11-17 16:17 1056

QBiotics' STELFONTA® Receives FDA Approval for Canine Mast cell Tumours

* STELFONTA (tigilanol tiglate injection) is now approved by the U.S. Food and Drug Administration's Center for Veterinary Medicine for the treatment of non-metastatic mast cell tumours (MCT) in dogs, making it the first pharmaceutical treatment available for all grades of canine non-metastati...

2020-11-17 11:51 3086

Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus

SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based inShanghai, China, announced that, after consulting with the U.S. Food and Drug Administration (FDA), the Company has initiated a Phase Ib/IIa clinical study of KPG-818 in patients with Systemic Lup...

2020-11-17 09:00 2670

Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases

MELBOURNE, Australia, Nov. 16, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the allowance of a new composition of matter patent by the United States Patent and Trademark Office (USPTO). The new patent is the product of in-ho...

2020-11-17 01:09 1394

Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device

YOQNEAM, Israel, Nov. 17, 2020 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive aesthetic medical devices, announced today that it has secured CE Mark (Conformité Européenne) for its next-generation Sofwave system which was approved for use for the treatment of fi...

2020-11-17 01:00 1670

Covis Group Completes Acquisition of AMAG Pharmaceuticals

LUXEMBOURG and ZUG, Switzerland, Nov. 16, 2020 /PRNewswire/ -- Covis Group S.à r.l. ("Covis") today announced the completion of its acquisition of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) through the successful tender offer for all of the outstanding shares of common stock of AMAG at$13.75 per s...

2020-11-16 22:43 3974

Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World's Evolving Healthcare Needs

PITTSBURGH, Nov. 16, 2020 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) launched today following the successful combination of Mylan N.V. and Pfizer's Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing and distribution expertise with pr...

2020-11-16 20:30 1655
1 ... 327328329330331332333 ... 397

Week's Top Stories